From Fossil Fuels to Green Futures: Oxford and EBC Financial Group on What’s Holding Us Back
05 déc. 2024 03h00 HE
|
EBC Financial Group
EBC and University of Oxford’s WERD Series panel explores global economic growth and climate resilience, spotlighting the role of policies and finance.
EBC Financial Group and the University of Oxford’s Department of Economics Announce WERD Episode on Macroeconomics and Climate
23 oct. 2024 07h20 HE
|
EBC Financial Group
EBC and University of Oxford explore macroeconomic policies for climate resilience and sustainable growth in the WERD 2024-25 webinar series.
OXFORD ALUMNI PAKISTAN Opposes the Use of Oxford’s Name for Political Gains
15 oct. 2024 10h35 HE
|
Oxford Alumni Pakistan
Lahore, Pakistan, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Following the “National Dialogue on Pakistan’s Permacrisis” event held yesterday at the Governor House Lahore, Oxford Alumni Pakistan announced...
Beltway Grid analyzes Imran Khan’s candidature for Oxford Chancellor
15 oct. 2024 10h12 HE
|
Beltway Grid
London, United Kingdom, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Renowned policy advocacy group Beltway Grid has analyzed the recent Legal Opinion by the prestigious King’s Counsel Hugh Southey of the...
Former UK Prime Minister David Cameron Joins Oxford-Harrington Rare Disease Centre (OHC) as Chair of its Advisory Council
15 oct. 2024 02h00 HE
|
Oxford-Harrington Rare Disease Centre
Lord Cameron will lead international efforts to drive the OHC’s mission of delivering 40 new therapies for rare diseases into clinical trials over the next ten years OXFORD, UK and CLEVELAND,...
OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024
05 août 2024 09h08 HE
|
OMass Therapeutics
PRESS RELEASE OMass Therapeutics Selected by Fierce Biotech as a “Fierce 15” Winner for 2024 Oxford, United Kingdom – 5th August 2024 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology...
New AI agent for venture capital: 100x cheaper, 5x faster and on-par quality with humans
05 juin 2024 08h00 HE
|
Vela Partners
Vela Partners & The University of Oxford publish research on a new LLM and AI agent that make investment decisions 100x cheaper and 5x faster than humans.
Appointment of Stephen M. Deitsch as new Chief Financial Officer
04 avr. 2024 11h43 HE
|
ORGANOX LIMITED
OrganOx Appoints Stephen M. Deitsch, an experienced medtech finance leader with proven track record with IPOs, as new Chief Financial Officer.
LA&CCA Announces Collaborative Initiative with The University of Oxford for Scholarship Opportunity for Online Executive Diploma in Strategy & Innovation
25 janv. 2024 20h00 HE
|
LA&CCA
LA&CCA offers Oxford scholarship for executives in strategy and innovation—apply by Feb 2.
Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing
23 janv. 2024 07h00 HE
|
Oxford BioMedica plc
Oxford Biomedica is hosting a free webinar to share clients’ success stories in viral vector manufacturing Oxford, UK – 23 January 2024: On Wednesday 7 February, Oxford Biomedica, a quality and...